Clover Health Investments, Corp.
Simbolis: CLOV
NASDAQ
0.737
USDRinkos kaina šiandien
-2.6255
P/E santykis
0.0000
PEG koeficientas
362.87M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Clover Health Investments, Corp. (CLOV) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 242.7 | 555.3 | 791.2 | |||||
balance-sheet.row.short-term-investments | 0 | 119.8 | 231 | 315.3 | |||||
balance-sheet.row.net-receivables | 0 | 113.8 | 147.2 | 62.3 | |||||
balance-sheet.row.inventory | 0 | 70 | -101.9 | -153.9 | |||||
balance-sheet.row.other-current-assets | 0 | 1.4 | 24.4 | 52.9 | |||||
balance-sheet.row.total-current-assets | 0 | 428 | 625 | 752.5 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 8.5 | 9.8 | 7.7 | |||||
balance-sheet.row.goodwill | 0 | 0 | 11.7 | 1.2 | |||||
balance-sheet.row.intangible-assets | 0 | 3 | 8.3 | 3 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3 | 20 | 4.2 | |||||
balance-sheet.row.long-term-investments | 0 | 121 | 138.1 | 175.9 | |||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.other-non-current-assets | 0 | 10.2 | 15.7 | 10.4 | |||||
balance-sheet.row.total-non-current-assets | 0 | 142.7 | 183.6 | 198.3 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 570.7 | 808.6 | 950.8 | |||||
balance-sheet.row.account-payables | 0 | 37.2 | 32.4 | 28.1 | |||||
balance-sheet.row.short-term-debt | 0 | 1.7 | 1.8 | 3.1 | |||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.long-term-debt-total | 0 | 3 | 4 | 24.8 | |||||
Deferred Revenue Non Current | 0 | 3.1 | 0 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 80.6 | 264.4 | 175.6 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 23.2 | 20.2 | 38.9 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 4.7 | 5.9 | 7.9 | |||||
balance-sheet.row.total-liab | 0 | 284.3 | 460.9 | 411.5 | |||||
balance-sheet.row.preferred-stock | 0 | 316.2 | 395.1 | 616 | |||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | 0 | -2159.8 | -1955.6 | -1616.7 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.4 | -9.4 | -1.9 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2132.3 | 1917.6 | 1541.9 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 286.4 | 347.7 | 539.3 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 570.7 | 808.6 | 950.8 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 3.9 | |||||
balance-sheet.row.total-equity | 0 | 286.4 | 347.7 | 543.2 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 2 | 369.1 | 491.2 | |||||
balance-sheet.row.total-debt | 0 | 4.7 | 5.9 | 27.8 | |||||
balance-sheet.row.net-debt | 0 | -118.2 | -97.9 | -272.1 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -213.4 | -338.8 | -587.8 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 2.5 | 1.2 | 1.2 | |||||
cash-flows.row.deferred-income-tax | 0 | -4.7 | 0 | -66.1 | |||||
cash-flows.row.stock-based-compensation | 0 | 140.9 | 164.3 | 163.7 | |||||
cash-flows.row.change-in-working-capital | 0 | -55.4 | 98.3 | 192.7 | |||||
cash-flows.row.account-receivables | 0 | 4.8 | -8 | -9.4 | |||||
cash-flows.row.inventory | 0 | -4.8 | 8 | 9.4 | |||||
cash-flows.row.account-payables | 0 | 4.7 | 7.6 | 5.3 | |||||
cash-flows.row.other-working-capital | 0 | -64.9 | 90.7 | 187.4 | |||||
cash-flows.row.other-non-cash-items | 0 | 14.2 | -128.9 | 13.9 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.6 | -4.5 | -0.7 | |||||
cash-flows.row.acquisitions-net | 0 | -140.6 | -16.2 | 434.7 | |||||
cash-flows.row.purchases-of-investments | 0 | -175.6 | -369.6 | -876.3 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 316.2 | 485.4 | 441.5 | |||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | -434.7 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 140 | 95.1 | -435.4 | |||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | -30.9 | |||||
cash-flows.row.common-stock-issued | 0 | 1.1 | 1.4 | 289.9 | |||||
cash-flows.row.common-stock-repurchased | 0 | -6.2 | -6.4 | -0.1 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.3 | |||||
cash-flows.row.other-financing-activites | 0 | -28.8 | 82.4 | 666.9 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -33.9 | -5 | 925.4 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -106.2 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | -9.7 | -113.8 | 207.6 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 176.5 | 186.2 | 300 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 186.2 | 300 | 92.3 | |||||
cash-flows.row.operating-cash-flow | 0 | -115.9 | -203.9 | -282.3 | |||||
cash-flows.row.capital-expenditure | 0 | -0.6 | -4.5 | -0.7 | |||||
cash-flows.row.free-cash-flow | 0 | -116.5 | -208.4 | -283 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 2028.9 | 3476.7 | 1472 | |||||
income-statement-row.row.cost-of-revenue | 0 | 1776.4 | 3454 | 1551.2 | |||||
income-statement-row.row.gross-profit | 0 | 252.5 | 22.7 | -79.2 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -447.2 | -93 | 112.1 | |||||
income-statement-row.row.operating-expenses | 0 | 447.2 | 393.7 | 557.8 | |||||
income-statement-row.row.cost-and-expenses | 0 | -2216.4 | 3847.6 | 2109 | |||||
income-statement-row.row.interest-income | 0 | 0 | 1.4 | 16.9 | |||||
income-statement-row.row.interest-expense | 0 | 0 | 1.4 | 16.9 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -213.4 | 32.1 | 49.2 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -447.2 | -93 | 112.1 | |||||
income-statement-row.row.total-operating-expenses | 0 | -213.4 | 32.1 | 49.2 | |||||
income-statement-row.row.interest-expense | 0 | 0 | 1.4 | 16.9 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 2.5 | 1.2 | 1.2 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | -208.5 | -370.9 | -637 | |||||
income-statement-row.row.income-before-tax | 0 | -213.4 | -338.8 | -587.8 | |||||
income-statement-row.row.income-tax-expense | 0 | -208.5 | -33.4 | 16.9 | |||||
income-statement-row.row.net-income | 0 | -213.4 | -305.4 | -604.7 |
Dažnai užduodami klausimai
Kas yra Clover Health Investments, Corp. (CLOV) bendras turtas?
Clover Health Investments, Corp. (CLOV) bendras turtas yra 570671000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.262.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra -0.349.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra -0.087.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra -0.086.
Kas yra Clover Health Investments, Corp. (CLOV) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra -213361000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 4663000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 447237000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.